158 related articles for article (PubMed ID: 27717378)
1. Worst case optimization for interfractional motion mitigation in carbon ion therapy of pancreatic cancer.
Steitz J; Naumann P; Ulrich S; Haefner MF; Sterzing F; Oelfke U; Bangert M
Radiat Oncol; 2016 Oct; 11(1):134. PubMed ID: 27717378
[TBL] [Abstract][Full Text] [Related]
2. Probabilistic dose distribution from interfractional motion in carbon ion radiation therapy for prostate cancer shows rectum sparing with moderate target coverage degradation.
Bridges D; Kawamura H; Kanai T
PLoS One; 2018; 13(8):e0203289. PubMed ID: 30169520
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of Single Field Multi-Ion Particle Therapy Treatments.
Kopp B; Mein S; Dokic I; Harrabi S; Böhlen TT; Haberer T; Debus J; Abdollahi A; Mairani A
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):194-205. PubMed ID: 31610250
[TBL] [Abstract][Full Text] [Related]
4. Comparing the dosimetric impact of interfractional anatomical changes in photon, proton and carbon ion radiotherapy for pancreatic cancer patients.
Houweling AC; Crama K; Visser J; Fukata K; Rasch CR; Ohno T; Bel A; van der Horst A
Phys Med Biol; 2017 Apr; 62(8):3051-3064. PubMed ID: 28252445
[TBL] [Abstract][Full Text] [Related]
5. EUD-based biological optimization for carbon ion therapy.
Brüningk SC; Kamp F; Wilkens JJ
Med Phys; 2015 Nov; 42(11):6248-57. PubMed ID: 26520717
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
[TBL] [Abstract][Full Text] [Related]
7. Optimization of carbon ion and proton treatment plans using the raster-scanning technique for patients with unresectable pancreatic cancer.
Dreher C; Habermehl D; Ecker S; Brons S; El-Shafie R; Jäkel O; Debus J; Combs SE
Radiat Oncol; 2015 Nov; 10():237. PubMed ID: 26590103
[TBL] [Abstract][Full Text] [Related]
8. Optimizing 3DCT image registration for interfractional changes in carbon-ion prostate radiotherapy.
Hirai R; Mori S; Suyari H; Tsuji H; Ishikawa H
Sci Rep; 2023 May; 13(1):7448. PubMed ID: 37156901
[TBL] [Abstract][Full Text] [Related]
9. Spot-scanning hadron arc (SHArc) therapy: A proof of concept using single- and multi-ion strategies with helium, carbon, oxygen, and neon ions.
Mein S; Kopp B; Tessonnier T; Liermann J; Abdollahi A; Debus J; Haberer T; Mairani A
Med Phys; 2022 Sep; 49(9):6082-6097. PubMed ID: 35717613
[TBL] [Abstract][Full Text] [Related]
10. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
[TBL] [Abstract][Full Text] [Related]
11. Joint Optimization of Photon-Carbon Ion Treatments for Glioblastoma.
Bennan ABA; Unkelbach J; Wahl N; Salome P; Bangert M
Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):559-572. PubMed ID: 34058258
[TBL] [Abstract][Full Text] [Related]
12. A Monte Carlo-based treatment-planning tool for ion beam therapy.
Böhlen TT; Bauer J; Dosanjh M; Ferrari A; Haberer T; Parodi K; Patera V; Mairani A
J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i77-81. PubMed ID: 23824131
[TBL] [Abstract][Full Text] [Related]
13. Interfractional dose variations in the stomach and the bowels during breathhold intensity-modulated radiotherapy for pancreatic cancer: Implications for a dose-escalation strategy.
Nakamura A; Shibuya K; Nakamura M; Matsuo Y; Shiinoki T; Nakata M; Mizowaki T; Hiraoka M
Med Phys; 2013 Feb; 40(2):021701. PubMed ID: 23387724
[TBL] [Abstract][Full Text] [Related]
14. Robust treatment planning with 4D intensity modulated carbon ion therapy for multiple targets in stage IV non-small cell lung cancer.
Wolf M; Anderle K; Durante M; Graeff C
Phys Med Biol; 2020 Nov; 65(21):215012. PubMed ID: 32610300
[TBL] [Abstract][Full Text] [Related]
15. Biological Dose Optimization for Particle Arc Therapy Using Helium and Carbon Ions.
Mein S; Tessonnier T; Kopp B; Schömers C; Harrabi S; Abdollahi A; Debus J; Haberer T; Mairani A
Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):334-348. PubMed ID: 35490991
[TBL] [Abstract][Full Text] [Related]
16. Robustness of 4D-optimized scanned carbon ion beam therapy against interfractional changes in lung cancer.
Graeff C
Radiother Oncol; 2017 Mar; 122(3):387-392. PubMed ID: 28073579
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous optimization of RBE-weighted dose and nanometric ionization distributions in treatment planning with carbon ions.
Burigo LN; Ramos-Méndez J; Bangert M; Schulte RW; Faddegon B
Phys Med Biol; 2019 Jan; 64(1):015015. PubMed ID: 30523890
[TBL] [Abstract][Full Text] [Related]
18. Gated carbon-ion scanning treatment for pancreatic tumour with field specific target volume and organs at risk.
Miki K; Mori S; Shiomi M; Yamada S
Phys Med; 2016 Dec; 32(12):1521-1528. PubMed ID: 27884463
[TBL] [Abstract][Full Text] [Related]
19. Robust optimization of intensity modulated proton therapy.
Liu W; Zhang X; Li Y; Mohan R
Med Phys; 2012 Feb; 39(2):1079-91. PubMed ID: 22320818
[TBL] [Abstract][Full Text] [Related]
20. Adaptive planning based on single beam optimization in passive scattering carbon ion radiotherapy for patients with pancreatic cancer.
Li Y; Kubota Y; Okamoto M; Shiba S; Okazaki S; Matsui T; Tashiro M; Nakano T; Ohno T
Radiat Oncol; 2021 Jun; 16(1):111. PubMed ID: 34147099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
